Unknown

Dataset Information

0

Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.


ABSTRACT: BACKGROUND:Staphylococcus aureus (S. aureus) causes a wide range of infectious diseases in human and animals. The emergence of antibiotic-resistant strains demands novel strategies for prophylactic vaccine development. In this study, live attenuated S. enterica subsp. enterica serotype Typhimurium (S. Typhimurium) vaccine against S. aureus infection was developed, in which Salmonella Pathogenesis Island-1 Type 3 Secretion System (SPI-1 T3SS) was employed to deliver SaEsxA and SaEsxB, two of ESAT-6-like (Early Secreted Antigenic Target-6) virulence factors of S. aureus. METHODS:Antigens SaEsxA and SaEsxB were fused with the N-terminal secretion and translocation domain of SPI-1 effector SipA. And cytosolic delivery of Staphylococcal antigens into macrophages was examined by western blot. BALB/c mice were orally immunized with S. Typhimurium-SaEsxA and S. Typhimurium-SaEsxB vaccines. Antigen-specific humoral and Th1/Th17 immune responses were examined by ELISA and ELISPOT assays 7-9 days after the 2nd booster. For ELISPOT assays, the statistical significance was determined by Student's t test. The vaccine efficacy was evaluated by lethal challenge with two S. aureus clinical isolates Newman strain and USA 300 strain. Statistical significance was determined by Log rank (Mantel-Cox) analysis. And a P value of

SUBMITTER: Xu C 

PROVIDER: S-EPMC5921394 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.

Xu Chen C   Zhang Bao-Zhong BZ   Lin Qiubin Q   Deng Jian J   Yu Bin B   Arya Smriti S   Yuen Kwok-Yung KY   Huang Jian-Dong JD   Huang Jian-Dong JD  

BMC infectious diseases 20180425 1


<h4>Background</h4>Staphylococcus aureus (S. aureus) causes a wide range of infectious diseases in human and animals. The emergence of antibiotic-resistant strains demands novel strategies for prophylactic vaccine development. In this study, live attenuated S. enterica subsp. enterica serotype Typhimurium (S. Typhimurium) vaccine against S. aureus infection was developed, in which Salmonella Pathogenesis Island-1 Type 3 Secretion System (SPI-1 T3SS) was employed to deliver SaEsxA and SaEsxB, two  ...[more]

Similar Datasets

| S-EPMC4645371 | biostudies-literature
| S-EPMC4469493 | biostudies-literature
| S-EPMC3264309 | biostudies-literature
| S-EPMC5216426 | biostudies-literature
| S-EPMC3412168 | biostudies-literature
| S-EPMC5064100 | biostudies-literature
| S-EPMC5533773 | biostudies-literature
| S-EPMC5006692 | biostudies-literature
| S-EPMC6275109 | biostudies-literature
2017-10-12 | GSE100665 | GEO